Immuron Ltd (IMRN) KPIs and segments
Close on Nov 13, 2026Market cap $7.06MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Immuron's business
Immuron's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Immuron's fiscal year ends June 30 — Q4 FY26 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q4 FY26 CQ2 2026 | Q4 FY25 CQ2 2025 | Q4 FY24 CQ2 2024 | Q4 FY23 CQ2 2023 | Q4 FY22 CQ2 2022 | Q4 FY21 CQ2 2021 | Q4 FY20 CQ2 2020 | Q4 FY19 CQ2 2019 | Q4 FY18 CQ2 2018 | Q4 FY17 CQ2 2017 | Q4 FY16 CQ2 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Corporate(A$M) | 9.47 | 7.28 | 11.9 | 19.5 | 22.9 | 25.2 | ||||||
Hyper-Immune Products(A$M) | 2.90 | 1.74 | 2.85 | 2.08 | 1.69 | 1.59 | 2.54 | 2.71 | 3.16 | 2.59 | 2.32 | |
Research and Development(A$M) | 0.78 | 1.11 | 0.77 | 0.40 | 0.26 | 0.31 | 0.31 | 0.53 | 1.19 | 1.50 | 1.51 | |
Earlier reporting (last reported 2022)1 | ||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-09-24.
See a number that looks wrong?